Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 12 studies | 33% ± 12% | |
epithelial cell | 5 studies | 26% ± 8% | |
retinal ganglion cell | 4 studies | 59% ± 22% | |
retinal cone cell | 4 studies | 28% ± 8% | |
oligodendrocyte precursor cell | 4 studies | 26% ± 6% | |
squamous epithelial cell | 3 studies | 34% ± 21% | |
CD4-positive, alpha-beta T cell | 3 studies | 17% ± 0% | |
GABAergic neuron | 3 studies | 45% ± 15% | |
glutamatergic neuron | 3 studies | 55% ± 15% | |
basal cell | 3 studies | 26% ± 10% | |
astrocyte | 3 studies | 19% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 3213.91 | 653 / 653 | 100% | 52.74 | 603 / 605 |
prostate | 98% | 6498.33 | 240 / 245 | 100% | 54.41 | 502 / 502 |
intestine | 100% | 2414.55 | 965 / 966 | 97% | 13.69 | 511 / 527 |
stomach | 99% | 1934.71 | 356 / 359 | 97% | 13.42 | 278 / 286 |
esophagus | 96% | 1615.22 | 1392 / 1445 | 99% | 14.94 | 181 / 183 |
pancreas | 98% | 1511.91 | 321 / 328 | 97% | 14.02 | 172 / 178 |
skin | 100% | 2396.40 | 1803 / 1809 | 95% | 35.66 | 447 / 472 |
lung | 97% | 1797.19 | 560 / 578 | 97% | 15.49 | 1124 / 1155 |
brain | 100% | 8729.70 | 2642 / 2642 | 94% | 22.87 | 663 / 705 |
kidney | 98% | 1834.64 | 87 / 89 | 94% | 19.99 | 850 / 901 |
breast | 92% | 1411.82 | 423 / 459 | 97% | 19.16 | 1079 / 1118 |
uterus | 89% | 1139.06 | 152 / 170 | 92% | 12.96 | 420 / 459 |
ovary | 79% | 879.46 | 143 / 180 | 94% | 12.87 | 405 / 430 |
adrenal gland | 94% | 1746.36 | 243 / 258 | 73% | 8.00 | 168 / 230 |
bladder | 62% | 775.33 | 13 / 21 | 94% | 12.79 | 473 / 504 |
tonsil | 0% | 0 | 0 / 0 | 100% | 17.48 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.87 | 1 / 1 |
spleen | 100% | 1256.88 | 240 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 10.31 | 26 / 29 |
heart | 84% | 1467.07 | 723 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 78% | 12.08 | 62 / 80 |
adipose | 74% | 868.51 | 888 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 53% | 713.48 | 490 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 39% | 394.19 | 518 / 1335 | 0% | 0 | 0 / 0 |
liver | 12% | 98.37 | 28 / 226 | 18% | 1.63 | 75 / 406 |
muscle | 18% | 139.65 | 142 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0015693 | Biological process | magnesium ion transport |
GO_1903830 | Biological process | magnesium ion transmembrane transport |
GO_0016020 | Cellular component | membrane |
GO_0015095 | Molecular function | magnesium ion transmembrane transporter activity |
GO_0005515 | Molecular function | protein binding |
Gene name | NIPAL3 |
Protein name | NIPA-like protein 3 NIPA like domain containing 3 |
Synonyms | NPAL3 |
Description | |
Accessions | ENST00000339255.2 A6NN97 ENST00000374399.9 [Q6P499-1] ENST00000003912.7 [Q6P499-2] ENST00000432012.1 ENST00000358028.8 [Q6P499-3] Q6P499 H0Y4I9 |